2016 Jul 20
The ‘Quantum Theory’ of cancer treatment
Silvia Formenti, M.D., and Sandra Demaria, M.D., describe the "abscopal effect." Read more
2016 Jul 19
Metabolic protein linked to cancer and autoimmunity
Scientists in the lab of Meyer director Lewis Cantley, Ph.D., have found that the gene PIP4K2C and its associated protein PI5P4Kγ play a role in the regulation of the immune system. Read more
2016 Jul 18
Pathway to collaboration
Karen Vousden, director of the Cancer Research UK Beatson Institute in Glasgow, Scotland, recently spent a month at the Meyer Cancer Center as part of the Vallee Visiting Professorship program. Read more
2016 Jul 16
Novel testing approaches better equip physicians to identify myeloma risks
Adriana Rossi, M.D., discusses how physicians are becoming better equipped to detect monoclonal gammopathy of undetermined significance, which may help identify patients at risk for myeloma. Read more
2016 Jul 15
Meyer members among Damon Runyon awardees
Chris Barbieri, M.D., Ph.D., and Heather Yeo, M.D., were among seven physician-scientists nationwide to be recognized with prestigious Damon Runyon awards. Read more
2016 Jul 15
Improving outcomes in resectable gastric cancer
Manish Shah, M.D., puts gastric cancer care in context, and underscores the importance of clinical trial participation. Read more
2016 Jul 15
Mom with breast cancer dreams up 'Glam Chemo' photo project
Breast cancer patient Marquina Iliev-Piselli approached her chemo treatments in a unique, creative way Read more
2016 Jul 14
Wealthy white men more likely to get robotic surgery
Jim Hu, M.D., weighs in on an analysis of robotic surgery use in New York. Read more
2016 Jul 13
Doctors using virtual reality to treat cancer patients
TV news segment features virtual reality technology from the lab of Olivier Elemento, Ph.D. Read more
2016 Jul 12
Unrealistic expectations may hinder blood cancer patients' care
Kelly Trevino, Ph.D., comments on a study about end-of-life care for blood cancer patients. Read more
2016 Jul 11
Engineered human colon model could aid in cancer research
Postdoctoral fellow Joyce Chen has helped develop a new human colon model. Read more
2016 Jul 11
Englander Institute creates big data solution
A cross-institutional team of clinical IT staff and computational biologists from several departments at Weill Cornell Medicine has successfully linked IPM reports into the Epic electronic medical record (EMR) management system in use by Weill Cornell Physicians in a highly detailed, computer-readable format. Read more
2016 Jul 10
Is MRD negativity necessary for CLL patients?
Richard Furman, M.D., argues that a partial, ongoing response on novel agent therapy may be preferable for chronic lymphocytic leukemia patients. Read more
2016 Jul 08
Weill Cornell will help lead national precision medicine effort
A $4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals/Harlem a key role in new NIH precision medicine cohort program Read more
2016 Jul 07
Understanding CA-125
Kevin Holcomb, M.D., explains what the CA-125 blood test means for diagnosis and clinical management of ovarian cancer. Read more
2016 Jul 06
Leading researchers recommend major change in prostate cancer treatment
Meyer Cancer Center researchers are part of an international team encouraging advanced prostate cancer patients to get genetic testing for DNA-repair gene mutations. Read more
2016 Jul 01
What doctors know about how bad it is, and won’t say
Many terminal cancer patients don't realize they are dying, according to a study by Holly Prigerson, Ph.D. Read more
2016 Jul 01
Not just a shot in the dark
Researchers and clinicians gather to reflect on Cancer Moonshot mission Read more
2016 Jun 30
Weill Cornell joins national Oncology Care Model project
Weill Cornell Medicine, NewYork-Presbyterian and Columbia University Medical Center are among nearly 200 physician group practices and 17 health insurance companies participating in the Medicare arm of the Oncology Care Model, which includes more than 3,200 oncologists. Read more
2016 Jun 29
FDA grants Napabucasin orphan status for gastric cancer
The FDA has granted an orphan drug designation to the STAT3-targeted agent napabucasin as a treatment for patients with gastric or gastroesophageal junction cancer, based on early-phase research by Manish Shah, M.D. Read more
